985 related articles for article (PubMed ID: 29278724)
21. Frequency of reported pain in adult males with muscular dystrophy.
Jacques MF; Stockley RC; Bostock EI; Smith J; DeGoede CG; Morse CI
PLoS One; 2019; 14(2):e0212437. PubMed ID: 30763387
[TBL] [Abstract][Full Text] [Related]
22. Muscle MRI findings in facioscapulohumeral muscular dystrophy.
Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L
Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655
[TBL] [Abstract][Full Text] [Related]
23. Protein and energy metabolism in patients with progressive muscular dystrophy.
Okada K; Manabe S; Sakamoto S; Ohnaka M; Niiyama Y
J Nutr Sci Vitaminol (Tokyo); 1992 Apr; 38(2):141-54. PubMed ID: 1506920
[TBL] [Abstract][Full Text] [Related]
24. Dystrophin immunostaining in muscles from patients with different types of muscular dystrophy: a Brazilian study.
Vainzof M; Pavanello RC; Pavanello Filho I; Passos-Bueno MR; Rapaport D; Hsi CT; Zatz M
J Neurol Sci; 1990 Sep; 98(2-3):221-33. PubMed ID: 1700808
[TBL] [Abstract][Full Text] [Related]
25. The cardiorespiratory response and physiological determinants of the assisted 6-minute handbike cycle test in adult males with muscular dystrophy.
Morse CI; Bostock EL; Twiss HM; Kapp LH; Orme P; Jacques MF
Muscle Nerve; 2018 Sep; 58(3):427-433. PubMed ID: 29669172
[TBL] [Abstract][Full Text] [Related]
26. Upper extremity function and activity in facioscapulohumeral dystrophy and limb-girdle muscular dystrophies: a systematic review.
Bergsma A; Cup EH; Geurts AC; de Groot IJ
Disabil Rehabil; 2015; 37(12):1017-32. PubMed ID: 25098592
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and new treatments in muscular dystrophies.
Manzur AY; Muntoni F
J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):706-14. PubMed ID: 19531685
[TBL] [Abstract][Full Text] [Related]
28. Valley sign in Becker muscular dystrophy and outliers of Duchenne and Becker muscular dystrophy.
Pradhan S
Neurol India; 2004 Jun; 52(2):203-5. PubMed ID: 15269471
[TBL] [Abstract][Full Text] [Related]
29. Decorin and biglycan expression is differentially altered in several muscular dystrophies.
Zanotti S; Negri T; Cappelletti C; Bernasconi P; Canioni E; Di Blasi C; Pegoraro E; Angelini C; Ciscato P; Prelle A; Mantegazza R; Morandi L; Mora M
Brain; 2005 Nov; 128(Pt 11):2546-55. PubMed ID: 16183658
[TBL] [Abstract][Full Text] [Related]
30. Objective and subjective measures of sleep in men with Muscular Dystrophy.
Morse CI; Onambele-Pearson G; Edwards B; Wong SC; Jacques MF
PLoS One; 2022; 17(9):e0274970. PubMed ID: 36137167
[TBL] [Abstract][Full Text] [Related]
31. An Open Label Exploratory Clinical Trial Evaluating Safety and Tolerability of Once-Weekly Prednisone in Becker and Limb-Girdle Muscular Dystrophy.
Zelikovich AS; Joslin BC; Casey P; McNally EM; Ajroud-Driss S
J Neuromuscul Dis; 2022; 9(2):275-287. PubMed ID: 35124660
[TBL] [Abstract][Full Text] [Related]
32. Serum CK-MB activity in progressive muscular dystrophy: is it of nosologic value?
Vainzof M; Zatz M; Otto PA
Am J Med Genet; 1985 Sep; 22(1):81-7. PubMed ID: 4050853
[TBL] [Abstract][Full Text] [Related]
33. An overexpression of fibroblast growth factor (FGF) and FGF receptor 4 in a severe clinical phenotype of facioscapulohumeral muscular dystrophy.
Saito A; Higuchi I; Nakagawa M; Saito M; Uchida Y; Inose M; Kasai T; Niiyama T; Fukunaga H; Arimura K; Osame M
Muscle Nerve; 2000 Apr; 23(4):490-7. PubMed ID: 10716758
[TBL] [Abstract][Full Text] [Related]
34. Cross-sectional serum metabolomic study of multiple forms of muscular dystrophy.
Spitali P; Hettne K; Tsonaka R; Sabir E; Seyer A; Hemerik JBA; Goeman JJ; Picillo E; Ergoli M; Politano L; Aartsma-Rus A
J Cell Mol Med; 2018 Apr; 22(4):2442-2448. PubMed ID: 29441734
[TBL] [Abstract][Full Text] [Related]
35. Free intramuscular Mg
Reyngoudt H; Lopez Kolkovsky AL; Carlier PG
NMR Biomed; 2019 Sep; 32(9):e4115. PubMed ID: 31184793
[TBL] [Abstract][Full Text] [Related]
36. Non-Invasive Biomarkers for Duchenne Muscular Dystrophy and Carrier Detection.
Anaya-Segura MA; García-Martínez FA; Montes-Almanza LA; Díaz BG; Avila-Ramírez G; Alvarez-Maya I; Coral-Vazquez RM; Mondragón-Terán P; Escobar-Cedillo RE; García-Calderón N; Vazquez-Cardenas NA; García S; López-Hernandez LB
Molecules; 2015 Jun; 20(6):11154-72. PubMed ID: 26091074
[TBL] [Abstract][Full Text] [Related]
37. Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies.
Spitali P; Hettne K; Tsonaka R; Charrout M; van den Bergen J; Koeks Z; Kan HE; Hooijmans MT; Roos A; Straub V; Muntoni F; Al-Khalili-Szigyarto C; Koel-Simmelink MJA; Teunissen CE; Lochmüller H; Niks EH; Aartsma-Rus A
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):715-726. PubMed ID: 29682908
[TBL] [Abstract][Full Text] [Related]
38. Multivoxel proton magnetic resonance spectroscopy in facioscapulohumeral muscular dystrophy.
Leung DG; Wang X; Barker PB; Carrino JA; Wagner KR
Muscle Nerve; 2018 Jun; 57(6):958-963. PubMed ID: 29266323
[TBL] [Abstract][Full Text] [Related]
39. The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United States.
Reddy HM; Cho KA; Lek M; Estrella E; Valkanas E; Jones MD; Mitsuhashi S; Darras BT; Amato AA; Lidov HG; Brownstein CA; Margulies DM; Yu TW; Salih MA; Kunkel LM; MacArthur DG; Kang PB
J Hum Genet; 2017 Feb; 62(2):243-252. PubMed ID: 27708273
[TBL] [Abstract][Full Text] [Related]
40. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
Wang S; Shen D
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
